Try our corporate solution for free!
(212) 419-8294
vianny.gutierrez-cruz@statista.com

Operating loss of BioNTech 2017-2020

Published by
Matej Mikulic,
Mar 31, 2021
In 2020, the annual operating loss of biotech company BioNTech SE was around 82.4 million euros, compared to around 181.5 million in the previous year. This statistic illustrates the annual operating loss of BioNTech SE from 2017 to 2020, in thousand euros. On November 9th 2020, German biotech company BioNTech in cooperation with U.S. pharma giant Pfizer were the first to announce a proven COVID-19 vaccine to be ready for mass production by year-end.

Operating loss of BioNTech SE from 2017 to 2020 (in 1,000 euros)

Loading statistic...

© Statista 2022
You need to log in to download this statistic
Register for free
Already a member?
Log in
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Coronavirus: the pharma and medtech response"

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Further Content: You might find this interesting as well

Statistics

Topics

mRNA technologyBiotech drug industryBiotechnology industry in Germany Biotechnology in EuropeCoronavirus (COVID-19) vaccines and treatments
Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
Menu